Xiamen Amoytop Biotech Co., Ltd. (688278.SS)
CNY 71.53
(1.26%)
CNY 71.53
(1.26%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 7.92 Million CNY | -18.66% |
| 2022 | 9.74 Million CNY | -61.29% |
| 2021 | 25.16 Million CNY | 33.02% |
| 2020 | 18.91 Million CNY | -68.52% |
| 2019 | 60.09 Million CNY | -14.15% |
| 2018 | 70 Million CNY | -12.5% |
| 2017 | 80 Million CNY | -9.32% |
| 2016 | 88.22 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 7.52 Million CNY | -5.03% |
| 2024 Q2 | 10.2 Million CNY | 35.55% |
| 2024 Q3 | 4.45 Million CNY | -46.57% |
| 2023 Q4 | 7.92 Million CNY | -16.55% |
| 2023 Q3 | 9.49 Million CNY | -12.62% |
| 2023 Q1 | 9 Million CNY | -7.54% |
| 2023 FY | 7.92 Million CNY | -18.66% |
| 2023 Q2 | 10.86 Million CNY | 20.65% |
| 2022 Q2 | 21.73 Million CNY | -8.23% |
| 2022 Q1 | 23.68 Million CNY | -5.86% |
| 2022 Q3 | 10.52 Million CNY | -51.6% |
| 2022 FY | 9.74 Million CNY | -61.29% |
| 2022 Q4 | 9.74 Million CNY | -7.42% |
| 2021 Q1 | 30.8 Million CNY | 62.85% |
| 2021 Q2 | 35.07 Million CNY | 13.84% |
| 2021 Q4 | 25.16 Million CNY | -2.62% |
| 2021 Q3 | 25.84 Million CNY | -26.32% |
| 2021 FY | 25.16 Million CNY | 33.02% |
| 2020 Q4 | 18.91 Million CNY | 3.17% |
| 2020 Q1 | 60.09 Million CNY | 0.0% |
| 2020 FY | 18.91 Million CNY | -68.52% |
| 2020 Q3 | 18.33 Million CNY | -69.48% |
| 2020 Q2 | 60.08 Million CNY | -0.01% |
| 2019 Q3 | 60.08 Million CNY | -14.3% |
| 2019 FY | 60.09 Million CNY | -14.15% |
| 2019 Q4 | 60.09 Million CNY | 0.01% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 Q2 | 70.1 Million CNY | 0.0% |
| 2018 FY | 70 Million CNY | -12.5% |
| 2018 Q4 | 70 Million CNY | 0.0% |
| 2017 FY | 80 Million CNY | -9.32% |
| 2016 FY | 88.22 Million CNY | 0.0% |